Source: Applied Cancer Research. Conference titles: São Paulo Research Conference-Cancer. Unidade: FM
Subjects: METALOPROTEINASES, MELANOMA, PROLIFERAÇÃO CELULAR
ABNT
COSTA, E. T. et al. Tumoral metastatic specialization: A progression to a pre-malignant phenotype associated with loss of adam 23 expression. Applied Cancer Research, v. 27, n. 2, p. 76, 2007Tradução . . Acesso em: 10 set. 2024.APA
Costa, E. T., Verbisck, N. V., Chammas, R., Costa, F. F., & Camargo, A. A. (2007). Tumoral metastatic specialization: A progression to a pre-malignant phenotype associated with loss of adam 23 expression. Applied Cancer Research, 27( 2), 76.NLM
Costa ET, Verbisck NV, Chammas R, Costa FF, Camargo AA. Tumoral metastatic specialization: A progression to a pre-malignant phenotype associated with loss of adam 23 expression. Applied Cancer Research. 2007 ; 27( 2): 76.[citado 2024 set. 10 ]Vancouver
Costa ET, Verbisck NV, Chammas R, Costa FF, Camargo AA. Tumoral metastatic specialization: A progression to a pre-malignant phenotype associated with loss of adam 23 expression. Applied Cancer Research. 2007 ; 27( 2): 76.[citado 2024 set. 10 ]